Best Practices in Biomarker Testing Documentation
Last Updated: Wednesday, February 15, 2023
Beth Sandy, MSN, CRNP, of the University of Pennsylvania Abramson Cancer Center, and Eve Segal, PharmD, BCOP, of the Seattle Cancer Care Alliance/University of Washington, discuss the importance of placing biomarker testing results in a consistent place within the patient’s electronic medical records for ready access by everyone on the care team. They also discuss why biomarker testing is critical in shaping a patient’s treatment and the reasoning behind doing a re-biopsy if the cancer recurs.
Meet the faculty
![](/media/0emhlnzm/sandy-b.jpeg)
Beth Sandy
MSN, CRNP
University of Pennsylvania Abramson Cancer Center
Ms. Sandy is a nurse practitioner specializing in thoracic malignancies. She serves on various editorial boards and has published in several peer-reviewed medical journals. She speaks nationally and internationally on the topics of lung cancer and the supportive care needs of patients with lung cancer.
![](/media/3sqnat3l/segal-e.png)
Eve Segal
PharmD, BCOP
Seattle Cancer Care Alliance/University of Washington
Dr. Segal is a clinical pharmacy specialist whose primary responsibilities include collaborating with the medical oncology team in the care of patients with a variety of solid tumors. She has authored and coauthored several publications in various peer-reviewed medical journals.